Cornercap Investment Counsel’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
Other funds holding IART
CB
CIP
Cornercap Investment Counsel's IART Position: Q4 2023 in Review
Cornercap Investment Counsel sold out of Integra LifeSciences (IART) in Q4 2023, closing a stake of 24,927 shares — an estimated $952K sold.
Cornercap Investment Counsel first reported a position in IART in Q2 2013 and held it in 15 quarters. The position peaked at $1.71M in Q2 2013. 284 funds tracked by Wall St. Rank hold IART as of Q4 2023.
- Cornercap Investment Counsel reported no remaining Integra LifeSciences position as of Q4 2023 after selling out during the quarter.
- Cornercap Investment Counsel sold 24,927 Integra LifeSciences shares in Q4 2023, an estimated $952K.
- Cornercap Investment Counsel first reported a position in Integra LifeSciences in Q2 2013 and held it in 15 quarters.
- Cornercap Investment Counsel's Integra LifeSciences position peaked at $1.71M in Q2 2013.
- 284 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2023.
Based on Cornercap Investment Counsel's 13F filing for Q4 2023, filed 30 Jan 2024.